Pinnacle GI Partners partnered with Michigan Gastroenterology Institute and Capitol Colorectal Surgery on Jan. 8, just slightly over a month after its formation. Lansing, Mich.-based Michigan Gastroenterology Institute was formed in 1988. Its team of gastroenterologists and advanced practice providers staff 12 facilities in Lansing. Lansing-based Capitol Colorectal Surgery has provided surgical care in Lansing for more than 40 years.
Author: Praveen Suthrum
COVID-19-related delays devastated the gastroenterology sector at the height of the initial surge. Managed Healthcare Executive reviewed monthly procedure volumes from an unidentified commercial health plan’s medical claims dataset and reported key findings Jan. 11. The health plan has more than a million members. Here’s what you should know: 1. In April 2020, procedure volume fell about 50 percent, and recovered by June. The drop in April represented 1.4 million procedures accounting for a medical spend of about $200 million. 2. From March 2020 to May 2020, the health plan members stopped receiving colonoscopies. Regular volume of 7,500 colonoscopies a month dropped…
Investing firm Assured Healthcare Partners partnered with West Long Branch, N.J.-based Allied Digestive Health, it announced Jan. 13. Assured partnered with Allied Digestive Health to support its growth in New Jersey and other northeast markets. The practice has more than 65 physicians providing care across 35 locations and several ancillary services. Allied Digestive Health employs more than 200 employees. Bob Gialanella, MD, president and CEO of Allied Digestive Health, said: “We’re excited to partner with AHP to accelerate the next phase of our growth in New Jersey and beyond. We will continue to strive to be the most attractive option…
2020 was a year like no other …but it’s now time to reimagine gastroenterology Through the ups and downs of COVID-19, 25+ GI leaders shared their fears, triumphs, ideas and insights through the SF podcast. A heartfelt thank you to everyone who contributed their time and perspective. This recap video is our thank-you to the GI community. Keep scoping forward! Regards, Praveen
John Allen, M.D is the Chief Clinical Officer of the University of Michigan Medical Group and is also on the board of Allina Health. In 2019, AGA presented its highest honor, the Julius Friedenwald Medal for his contributions to gastroenterology. Previously, he was the chief of Digestive Diseases at Yale and helped build Minnesota Gastroenterology (now MNGI), one of the largest GI practices in the country. This interview is so insightful that it’ll help you make several business and personal decisions for the long haul. Here’s specifically what you’ll take away: 1) What does it take lead calmly and steadily…
Freenome’s novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. Researchers examined results from 522 patients during the study. Compared to the FDA-approved mSEPT9 blood test, Freenome’s test had a higher sensitivity (41 percent to 22 percent). Compared to stool-based tests, Freenome’s sensitivity for advanced adenomas outperformed fecal immunochemical testing (24 percent) and was comparable to FIT-DNA testing (42 percent).
Fully covered self-expandable metal stents (FCSEMS) have increasingly been used in the endoscopic management of malignant and benign gastrointestinal diseases. The main limitation of FCSEMS is the risk of migration, occurring in at least one-third of patients. Different methods have been employed for anchorage of esophageal stent, as external fixation with endoscopic snare and internal fixation using both through-the-scope (TTS) and over-the scope (OTS) clips to fix the upper flared end of the FCSEMS to the esophageal mucosa.
This article was written by Dr. Alana Persaud, GI Fellow, SUNY Downstate, after attending the GI Forging Forward symposium “Effective Leadership in Times of Crisis.” Various leadership types abound, and during the COVID-19 crisis, they’ve been demonstrated at all levels. Two giants in gastroenterology, Drs. Barbara Jung and Hashem El-Serag outlined their role during the pandemic and how they adapted their leadership style to suit their responsibilities in a virtual symposium titled, “Effective Leadership in Times of Crisis.”
If there is any lesson to be drawn from 2020, it’s that making predictions for the year ahead is an act of hubris. Despite that, some clear trends have emerged. The pandemic has permeated every aspect of our lives: health, economics, politics, and beyond. Amid the devastation, the healthcare industry has been at the forefront. We face more questions than answers. How quickly can vaccines be efficiently distributed across the entire populace, rather than select groups? What strategies will businesses embrace to thrive (or survive) going forward? How will the new administration tackle its inherited challenges and advance its healthcare…
Richard M. Peek, MD, AGAF, and Douglas A. Corley, MD, PhD, MPH, AGAF, editors-in-chief of Gastroenterology, and Fasiha Kanwal, MD, MSHS, AGAF, editor-in-chief of Clinical Gastroenterology and Hepatology (CGH), provide their picks of top articles.